Testing version — LOERadar is in active testing. Features and data may change.
ENTOCORT EC (BUDESONIDE) | LOERadar
ENTOCORT EC
NDA
BUDESONIDE | N021324 | PADAGIS US LLC
1 strength0 unique patents0 unique exclusivities
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
Para IV certification filed but no ANDA patent litigation cases (NOS 835) matched from PACER. Litigation may be pending or filed under a different caption.
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — 3MG
RLDAB
0 patents0 exclusivities▴
CAPSULE, DELAYED RELEASE;ORAL | Approved: Oct 2, 2001
No patent or exclusivity listings for this strength.